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SOCIETY NEWS
Conflict of Interest: The “Interest” of ASHG
The concept of “conflict of interest” (COI) is not new to the
business or political communities and has been around for some
time in scientific research. COI is a situation rather than a be-
havior. Only in the past several years have policies and procedures
around reporting of COI emerged that recognized that these sit-
uations should be disclosed and managed. These policies and
procedures have become increasingly important as scientists from
the academic sector collaborate and contract with, obtain funds
from, and share scientific expertise with the for-profit business
sectors of the economy.
These relationships and the resulting situations are vital to the
growing biomedical research enterprise, and the sharing of re-
sources and talent is essential to the rapid advancement of ba-
sic research and its translation into clinical application. It is the
misuse of resources, intellectual or tangible, that must be avoided.
These complex relationships have increased concerns about the
risks that might be related to financial conflicts of interest. These
risks include the potential to bias research, affect study design
or protocol development, compromise the dissemination of re-
search results, and possibly diminish the public trust in biomed-
ical research.
Timely, accurate, complete, and balanced reporting of research
results are expected in the scientific community. Relationships,
especially those that remain occult, may lead to the perception
of COI or, more disturbingly, to the anticipation of poor behavior.
The Principles
Investigators have the responsibility to conduct their scientific
activities honestly and with the highest professional standards.
The ASHG Code of Ethics states objectivity as a principle of in-
tegrity, affirming the need to approach professional activities with
an unbiased attitude, gathering evidence and reporting results
fairly and precisely.
There is one basic and unifying approach to the challenges
presented by actual or perceived COI in research. That principle
is: disclose, disclose, disclose. If all relationships are clearly stated
and the relationships made transparent, then the underlying
principles of integrity in science can be upheld. In this open
milieu, COI situations can be appropriately managed.
Institutional Policies
Under federal law, academic institutions have the authority and
responsibility to establish and implement policies regarding re-
lationships with industry. State public universities may have ad-
ditional constraints under state law, as compared with private
institutions. Most institutions use a peer review system to mon-
itor these research relationships, usually under the guidance of
research and development, grants and contracts, or technology
transfer officials.
Every investigator’s primary obligation is to his or her employer
or institution and each is responsible for following all organi-
zational policies and procedures. Academic institutions have rec-
ognized that it is in the best interest of a university and its in-
vestigators to develop and enforce policies appropriately and con-
sistently. Although the variation among institutional policies may
be challenging, the community is gaining experience and the
sharing of best practices is creating a more transparent and shared
knowledge base.
As a professional scientific organization, ASHG also has respon-
sibilities in the disclosure and management of COI situations re-
lated to activities of the Society. To that end, every officer and
director must complete a COI form that remains on file and avail-
able upon request.
Annual Meeting
The most involved COI procedures for ASHG are related to the
Annual Meeting. ASHG believes that it is prudent to comply with
the most stringent applicable COI procedures. It is believed that
this transparency promotes the most integral involvement of sci-
entists working in all sectors of research. The implementation of
COI reporting protects the integrity of the research and the in-
vestigator and therefore encourages the participation of all sci-
entists in presenting at the annual meeting.
Continuing Medical Education (CME) Initiatives
When applying for permission to grant CME credits for the An-
nual Meeting, ASHG must comply with regulations and reporting
mechanisms that may seem onerous to some. In the larger con-
text of CME, there are situations in which seminars or symposia
may be presented by scientists clearly affiliated with companies,
such as pharmaceutical or equipment manufacturers. In some of
these cases, the relationship may not be very clear between the
science presented and advertising (subtle or not). ASHG strives
to avoid all compromised situations.
ASHG reports all disclosures, evaluates every presentation, and
manages potential conflicts by reporting all relationships. In our
case, each presentation, including invited speakers, accounts for
less than 1% of the total accumulation of hours that can be cred-
ited for CME. Also, each invited speaker and at least the title of
each presentation is reviewed by a peer review committee (the
Program Committee) and must be deemed to be of sufficient
scientific merit to be included in the program.
New Initiative
The Program Committee and the Society leadership have agreed
to adopt a policy used by many organizations for their meeting
presentations. Starting in San Diego in 2007, each presenter will
be required to use the second slide of the presentation (after the
title slide), to disclose all reportable relationships as listed on the
COI form. Explicit directions will be provided to all invited and
selected speakers.
Our organization will continue to strive for the goal of provid-
ing opportunities for all scientists to share their research results
in a context protected from any adverse COI situations.
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